Category: Intellectual property
-
Gene Therapy Company Starts-Up, Gains $200M
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million.
-
Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-
Gene Therapy Company Exploring DNA Circuit Technology
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits.
-
Univ. Lab Develops, Licenses Sports Injury Implant
A medical device company now offers a synthetic tissue implant for torn rotator cuff, a common sports injury, designed at a Purdue University engineering lab.
-
AbbVie Licenses Engineered Crispr Cell Process
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies.
-
Cancer Immunotherapy Adapted for HIV
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections.
-
Institutions Join Global Health Breakthrough Network
Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles.
-
Universities Form Joint Engineering Patent Pool
A group of 15 American universities are putting part of their engineering patents into a common licensing pool for commercial development.
-
Biotech Licenses mRNA Technology for Aging
A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging.
-
Drug Maker Gains Access to Hidden Protein Immunotherapies
Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells.